Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03214627 | Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial | ||
| NCT05861492 | FDDA Utilization Study (FDDAU) | ||
| NCT04616092 | Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery | ||
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | ||
| NCT00824460 | Study of Phosphate Levels in Patients With Chronic Kidney Disease | ||
| NCT06256991 | Potassium Correction for RAAS Optimization in Chronic Kidney Disease | ||
| NCT01394562 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure | ||
| NCT02687594 | Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) | ||
| NCT03888066 | Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT05766839 | Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT02243735 | Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia | ||
| NCT00868439 | Evaluation of Patiromer in Heart Failure Patients | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT04510792 | IMpact of HyPeRkalaemia on ThErapy with Renin AngiotenSin AldoSterone System Inhibitors | ||
| NCT01975272 | The Use of Iron Therapy for Patients With Anemia After Caesarean Section | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT01345968 | Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery | ||
| NCT00520780 | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT03071263 | Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease | ||
| NCT05885763 | Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT01131624 | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT01477424 | A Drug-Drug Interaction Study of Warfarin and PA21 | ||
| NCT00994318 | Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi | ||
| NCT05751772 | Improving Knowledge in Heart Failure Inpatient With Therapeutic Education | ||
| NCT05415969 | CKD-aP Among Adults on Dialysis in Switzerland | ||
| NCT02694744 | Patiromer With or Without Food for the Treatment of Hyperkalemia | ||
| NCT00810004 | Maintenance Treatment of Iron Deficiency in IBD Patients | ||
| NCT01513369 | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT05524467 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT00821717 | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT03591406 | To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia | ||
| NCT01820949 | Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients | ||
| NCT01452906 | A Drug-Drug Interaction Study of Omeprazole and PA21 |
